Cargando…
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
OBJECTIVES: Cisplatin‐based chemoradiation is an established organ‐preserving strategy for locally advanced laryngeal cancer, but long‐term survival remains suboptimal. Immunotherapy has been studied in the metastatic and unresectable recurrent settings. However, additional data are needed to assess...
Autores principales: | Frankart, Andrew J., Sadraei, Nooshin Hashemi, Huth, Brad, Redmond, Kevin P., Barrett, William L., Kurtzweil, Nicky, Riaz, Muhammad K., Wise‐Draper, Trisha, Rodriguez, Cristina P., Adelstein, David J., Takiar, Vinita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008154/ https://www.ncbi.nlm.nih.gov/pubmed/35434343 http://dx.doi.org/10.1002/lio2.780 |
Ejemplares similares
-
Standard chemoradiation versus intensity-modulated chemoradiation: a quality of life assessment in oropharyngeal cancer patients
por: Mowry, Sarah E., et al.
Publicado: (2009) -
Predictors of chemotherapy and its effects in early stage squamous cell carcinoma of the larynx
por: Jayakrishnan, Thejus T., et al.
Publicado: (2019) -
Defining targets to improve care delivery for T4 larynx squamous cell carcinoma
por: Frenkel, Catherine H., et al.
Publicado: (2022) -
Safety of flexible endoscopic biopsy of the pharynx and larynx under topical anesthesia
por: Wellenstein, David J., et al.
Publicado: (2017) -
Prognostic value of H‐index in patients surgically treated for squamous cell carcinoma of the larynx
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)